Injective CEO Eric Chen Meets White House, SEC and CFTC Officials on Regulated Onchain Finance

Injective CEO Eric Chen met with officials from the White House, the SEC and the CFTC in October 2026 to advance regulated onchain finance in the United States, the company said. Crypto Briefing reported that Chen was joined by other Injective leadership and that no new approvals were announced from the meetings.

Injective's Transfer Agent Status and RWA Push

Injective is a Layer-1 blockchain built for financial applications, combining a Cosmos SDK base with native EVM compatibility and a shared onchain orderbook. The company said the discussions centered on regulated onchain finance and the tokenization of real-world assets.

Injective arrived with a credential most crypto projects lack. In August 2026, the SEC registered it as a transfer agent, a status that lets it maintain the official ownership records for tokenized securities. The company also pointed to activity on its own network, reporting over $1 billion in tokenized RWA value onchain and cumulative RWA perpetual volume past $5.3 billion, spread across asset classes that include equities and commodities.

In 2025, Injective put forward a proposal calling for a time-based exemption for decentralized finance projects, giving early-stage protocols a window to develop before facing the full weight of securities rules. In September 2026, the SEC introduced its Innovation Exemption. INJ futures were listed on CFTC-regulated US markets in late 2026, and the Injective Summit hosted discussions with bipartisan members of Congress in earlier sessions.

Injective's Washington Policy Arm and Funding History

Injective established the Injective Policy Institute in Washington, DC in May 2026 as a policy and research arm engaging US regulators and lawmakers on the policy framework for onchain finance, according to akta.pro company records. The same records list five funding rounds, including a $40 million initial coin offering in August 2022 led by Jump Trading Group and a $10 million round in April 2021.

Injective's Earlier Deals and Launches

Injective partnered with BDACS in October 2026 to integrate KRW1, a won-backed stablecoin, into its RWA ecosystem, Crypto Briefing reported. The token, backed by Korean won held in escrow at Woori Bank, can be traded and settled on Injective, and its on-chain supply was about 13.67 million as of October 20, 2026.

Injective opened entries for its Stockdrop in October 2026, with eligible users who contributed to the INJ Community BuyBack able to claim tokenized stocks the following week, TradingView reported. Injective also launched a CCTP route for USDC through Lifi and Jumper in October 2026, aiming to deepen USDC liquidity on the network, TradingView reported.

What Comes Next for Injective

Injective has not announced any new approvals from the October 2026 meetings. The SEC's Innovation Exemption leaves open which projects qualify and on what terms.